Vanguard disaggregation: Eli Lilly (NYSE: LLY) ownership shows 0 shares
Rhea-AI Filing Summary
Eli Lilly & Co — Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned of Eli Lilly common stock, representing 0% of the class, following an internal realignment effective January 12, 2026. The filing states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; this amendment shows no reported beneficial ownership in LLY.
The filing records 0 shares and 0% ownership and explains an internal realignment on January 12, 2026 that caused subsidiaries to report separately in reliance on SEC Release No. 34-39538. This is an administrative disclosure describing reporting structure rather than a trading event.
Cash‑flow treatment or subsidiary-level share counts are not provided in this excerpt; subsequent filings by Vanguard subsidiaries may show holdings under their own names.
FAQ
Does The Vanguard Group own any Eli Lilly (LLY) shares in this amendment?
Why does the Schedule 13G/A show zero ownership for Vanguard in LLY?
Who signed the amendment for The Vanguard Group on this filing?
Does this Schedule 13G/A disclose subsidiary-level share counts for LLY?